Sanofi-Synthelabo U.S. Expansion Milestone Will Be 2002
Executive Summary
Sanofi-Synthelabo is likely to look to 2002 as the key date for the merged company to expand in the U.S.
You may also be interested in...
Sanofi-Aventis’ CEO Pipeline: R&D Chief Le Fur Tapped To Succeed Dehecq
Incoming Sanofi-Aventis CEO Gerard Le Fur will bring considerable research and development experience to the helm of the French drug maker
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011